Recurrent vulvar Buschke-Löwenstein's tumor-like condylomata acuminata and Hodgkin's disease effectively treated with recombinant interferon-alpha 2c gel as adjuvant to electrosurgery.
The local application of recombinant interferon-alpha 2c hydrogel (1 x 10(6) IU IFN-alpha 2c per g) given as an adjuvant after electrosurgery led to a complete cure of previously recalcitrant untreatable giant Buschke-Löwenstein's tumor-like condylomata acuminata of a 19-year-old patient suffering from Hodgkin's disease (stage II/II). Interferon-alpha 2c hydrogel given as adjuvant with surgery may have more direct antiproliferative and antiviral activities than immunomodulating defects. This combined topical application is an effective and safe treatment which is recommended especially in immunocompromised individuals suffering from genital HPV disease nonresponsive against systemic interferon and conventional therapy modalities.
Gross
G
G
Department of Dermatology, University of Hamburg-Eppendorf, FRG.
Roussaki
A
A
Pfister
H
H
D000328:Adult; D003131:Combined Modality Therapy; D003218:Condylomata Acuminata / Q000150:complications / Q000628:therapy*; D004598:Electrosurgery; D005260:Female; D006689:Hodgkin Disease / Q000150:complications*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007370:Interferon Type I / Q000627:therapeutic use*; D009894:Opportunistic Infections / Q000150:complications / Q000628:therapy*; D011994:Recombinant Proteins; D012008:Recurrence
D007370:Interferon Type I; D011994:Recombinant Proteins